Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Creator
-
Regan, Courtney
- Contributor
-
Nishimura, Michael
Clark, Ann Lau
Moxley, Kelly
Scurti, Gina
Slepushkin, Vladimir
Roy, André
Schonely, Kathy
Dropulic, Boro
Clark, Joseph
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P31
- URN
-
urn:nbn:de:1111-2016072655553
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Regan, Courtney
- Nishimura, Michael
- Clark, Ann Lau
- Moxley, Kelly
- Scurti, Gina
- Slepushkin, Vladimir
- Roy, André
- Schonely, Kathy
- Dropulic, Boro
- Clark, Joseph
- SpringerLink (Online service)
Other Objects (12)
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Development of a novel TCR avidity assay for human CD8+ T-cells
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
Deciphering TCR signaling in metabolically activated T-cells in NASH and liver cancer development
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Avidity characterization of genetically engineered T-cells with novel and established approaches
Recognition of renal cell carcinoma by CD8+ and CD4+ TCR-engineered T lymphocytes
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
TcR
Effects of desialyation on TCR-cross-linking and antigen sensitivity of CD8 positive T lymphocytes
P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Development of a novel TCR avidity assay for human CD8+ T-cells
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
Deciphering TCR signaling in metabolically activated T-cells in NASH and liver cancer development
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Avidity characterization of genetically engineered T-cells with novel and established approaches
Recognition of renal cell carcinoma by CD8+ and CD4+ TCR-engineered T lymphocytes
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
TcR
Effects of desialyation on TCR-cross-linking and antigen sensitivity of CD8 positive T lymphocytes
P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Development of a novel TCR avidity assay for human CD8+ T-cells
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
Deciphering TCR signaling in metabolically activated T-cells in NASH and liver cancer development
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Avidity characterization of genetically engineered T-cells with novel and established approaches
Recognition of renal cell carcinoma by CD8+ and CD4+ TCR-engineered T lymphocytes
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
TcR
Effects of desialyation on TCR-cross-linking and antigen sensitivity of CD8 positive T lymphocytes
P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer